- SEC approved the 19b-4 listing for Ethereum ETFs, but S-1 approval is awaited
- Bitcoin ETFs have been seeing massive inflows, with Ethereum expected to attract millions too
After much speculation surrounding the approval of Spot Ethereum [ETH] ETFs, the SEC gave a green light to these financial products a few days ago.
However, what’s significant here is that they’ve only approved the 19b-4 listing requests for ETH ETFs, not the critical S-1 registration statements.
What’s behind the split?
This split approval raises questions, with some suggesting a potential political influence rather than a careful review of the ETF proposals. Sharing a similar line of thought, Matt Hougan, CIO at Bitwise, during a recent episode of the ‘Bankless’ podcast said,
“I haven’t seen an example of people having no expectation of approval and flipping to expecting approval so quickly on an effectively overnight basis. So, to the extent that this has never happened again, something was shocking at work here.”
Reiterating the same, James Seyffart, Research Analyst at Bloomberg Intelligence, added,
Source: James Seyffart/X
When asked about the next steps in terms of an ETF, Hougan noted,
“The process between sort of where we are and these ETFs listing is: Issuers have to go back and forth with the division of investment management around exactly what’s in this document.”
Here, he highlighted that while the SEC’s approval of the 19b-4s is a significant step forward, the full launch of ETH ETFs depends on the S-1 document approval. This could take weeks to months.
Impact on ETH’s price
Needless to say, these developments contributed to significant fluctuations in Ethereum’s market cap, initially leading to a decline on the charts. However, at press time, ETH had rebounded to $3,752, up 1.65% in the last 24 hours. The wider market sentiment, led by Bitcoin climbing past $69k, had turned bullish too.
Bitwise CIO lent some insights to this matter too by stating,
“There’s no new supply, net supply is effectively zero and what that means is that this new demand shock has to buy ethereum from people who don’t have to sell it and that’s just an extraordinarily bullish setup.”
BTC inflows vs. ETH inflows
As far as spot Bitcoin [BTC] ETFs are concerned, since their debut on 11 January, the inflows have been phenomenal. In fact, recent data by Farside Investors revealed that on 24 May, Bitcoin ETFs saw total inflows of $251.9 million.
Source: Farside Investors
Will Ethereum see similar numbers though? According to Hougan, no. He went on to say,
“I don’t think Ethereum ETFs will match Bitcoin ETFs but I do think it will be measured in terms of many billions of dollars.”
The exec expanded on this point by emphasizing that Bitcoin’s simplicity as “digital gold” makes it easily understandable, while Ethereum’s role as a platform for decentralized applications is more complex.
Institutional investors, however, are likely to see the value of diversifying and diving into both BTC and ETH ETFs.
- SEC approved the 19b-4 listing for Ethereum ETFs, but S-1 approval is awaited
- Bitcoin ETFs have been seeing massive inflows, with Ethereum expected to attract millions too
After much speculation surrounding the approval of Spot Ethereum [ETH] ETFs, the SEC gave a green light to these financial products a few days ago.
However, what’s significant here is that they’ve only approved the 19b-4 listing requests for ETH ETFs, not the critical S-1 registration statements.
What’s behind the split?
This split approval raises questions, with some suggesting a potential political influence rather than a careful review of the ETF proposals. Sharing a similar line of thought, Matt Hougan, CIO at Bitwise, during a recent episode of the ‘Bankless’ podcast said,
“I haven’t seen an example of people having no expectation of approval and flipping to expecting approval so quickly on an effectively overnight basis. So, to the extent that this has never happened again, something was shocking at work here.”
Reiterating the same, James Seyffart, Research Analyst at Bloomberg Intelligence, added,
Source: James Seyffart/X
When asked about the next steps in terms of an ETF, Hougan noted,
“The process between sort of where we are and these ETFs listing is: Issuers have to go back and forth with the division of investment management around exactly what’s in this document.”
Here, he highlighted that while the SEC’s approval of the 19b-4s is a significant step forward, the full launch of ETH ETFs depends on the S-1 document approval. This could take weeks to months.
Impact on ETH’s price
Needless to say, these developments contributed to significant fluctuations in Ethereum’s market cap, initially leading to a decline on the charts. However, at press time, ETH had rebounded to $3,752, up 1.65% in the last 24 hours. The wider market sentiment, led by Bitcoin climbing past $69k, had turned bullish too.
Bitwise CIO lent some insights to this matter too by stating,
“There’s no new supply, net supply is effectively zero and what that means is that this new demand shock has to buy ethereum from people who don’t have to sell it and that’s just an extraordinarily bullish setup.”
BTC inflows vs. ETH inflows
As far as spot Bitcoin [BTC] ETFs are concerned, since their debut on 11 January, the inflows have been phenomenal. In fact, recent data by Farside Investors revealed that on 24 May, Bitcoin ETFs saw total inflows of $251.9 million.
Source: Farside Investors
Will Ethereum see similar numbers though? According to Hougan, no. He went on to say,
“I don’t think Ethereum ETFs will match Bitcoin ETFs but I do think it will be measured in terms of many billions of dollars.”
The exec expanded on this point by emphasizing that Bitcoin’s simplicity as “digital gold” makes it easily understandable, while Ethereum’s role as a platform for decentralized applications is more complex.
Institutional investors, however, are likely to see the value of diversifying and diving into both BTC and ETH ETFs.
I have read several excellent stuff here. Definitely worth bookmarking for revisiting. I surprise how much attempt you set to create such a magnificent informative web site.
What i don’t understood is actually how you’re no longer actually a lot more well-preferred than you might be right now. You’re so intelligent. You realize therefore considerably in terms of this matter, made me individually imagine it from numerous varied angles. Its like women and men aren’t interested except it’s something to accomplish with Woman gaga! Your individual stuffs excellent. Always handle it up!
Everything is very open and very clear explanation of issues. was truly information. Your website is very useful. Thanks for sharing.
buy clomid where buy clomiphene no prescription clomiphene price at clicks can i buy clomid can i order clomid prices can i buy clomid no prescription clomid medication effects
I am in truth enchant‚e ‘ to coup d’oeil at this blog posts which consists of tons of profitable facts, thanks towards providing such data.
More posts like this would make the online play more useful.
order azithromycin – buy ciprofloxacin 500 mg online metronidazole generic
semaglutide us – buy cyproheptadine 4mg generic how to get periactin without a prescription
domperidone 10mg cheap – buy tetracycline 500mg pills cyclobenzaprine 15mg us
brand augmentin 1000mg – atbioinfo order ampicillin pills
buy nexium 20mg online cheap – https://anexamate.com/ order nexium capsules
order coumadin – https://coumamide.com/ losartan over the counter
Thanks for the auspicious writeup. It actually was once a leisure account it. Look advanced to far brought agreeable from you! However, how could we communicate?
mobic medication – https://moboxsin.com/ mobic 7.5mg drug
buy prednisone 5mg online – https://apreplson.com/ deltasone 20mg ca
cheap erectile dysfunction pills online – site erection pills viagra online
buy diflucan 200mg generic – https://gpdifluca.com/# order diflucan 200mg without prescription
how much tadalafil to take – ciltad generic cialis 20mg side effects
where can i buy tadalafil online – on this site where can i buy cialis online in canada
ranitidine pills – https://aranitidine.com/# zantac 300mg uk